In the last decade, the cell sorting market has witnessed significant technological advancements and robust product developments. The global cell sorting market is projected to grow at a CAGR of 7.0% in the forecast period. Geographically, this market has been segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
North America and a major part of Europe are mature markets. The North American cell sorting market is expected to account for the largest share of the cell sorting market in 2016, owing to technological advancements, favorable business environment, government support through funds and grants, expanding biotechnology and pharmaceutical industries, growing number of research studies on cancer and HIV/AIDS, and the strong presence of key players in the North American Market. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is fueled by the growing incidence and prevalence of diseases such as cancer and HIV/AIDS, increasing research initiatives, expansions by key players in APAC countries, and technological advancements.
A number of players involved in the cell sorting market are Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Sony Biotechnology, Inc. (U.S.), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.).
Download Free Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=62606262
The key players in this market are focusing to strengthen their position in emerging markets by adopting both organic and inorganic growth strategies. For instance, in September 2016, Miltenyi Biotec GmbH (Germany) launched the Miltenyi Biotec Cell Therapy Centre of Excellence at the Monash Health Translation Precinct (MHTP), Australia. The new facility hosts a number of cell therapy products, including the company’s MACSQuant Tyto GMP Cell Sorter used for the development of treatment options for various diseases. Likewise, in August 2013, Sony Biotechnology, Inc. (U.S.) announced its operational expansion in the European region and showcased its SH800 Cell Sorter at the International Congress of Immunology (ICI) held in Milan, Italy. The company’s European head office is now located in the U.K. and support its England and France sales offices.
In addition, emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for market players owing to the growing incidence and prevalence of diseases such as cancer and HIV/AIDS, increasing research initiatives, and rising focus of market leaders in these countries. In India, the number of people diagnosed with cancer in 2012 increased to 14.1 million from an estimated 12.7 million in 2008 (Source: GLOBOCAN 2012). GLOBOCAN 2012 further estimates that the incidence of cancer will increase to ~19.3 million cases by 2025. Additionally, China’s health officials stated that in 2014, there were 104,000 new HIV/AIDS infections in China, a 14.8% increase from 2013 (Source: Dow Jones & Company, Inc.).
North America and a major part of Europe are mature markets. The North American cell sorting market is expected to account for the largest share of the cell sorting market in 2016, owing to technological advancements, favorable business environment, government support through funds and grants, expanding biotechnology and pharmaceutical industries, growing number of research studies on cancer and HIV/AIDS, and the strong presence of key players in the North American Market. However, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in this market is fueled by the growing incidence and prevalence of diseases such as cancer and HIV/AIDS, increasing research initiatives, expansions by key players in APAC countries, and technological advancements.
A number of players involved in the cell sorting market are Becton, Dickinson and Company (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Miltenyi Biotec GmbH (Germany), Sony Biotechnology, Inc. (U.S.), Affymetrix Inc. (U.S.), Sysmex Partec GmbH (Japan), On-Chip Biotechnologies Co., Ltd. (Japan), Cytonome/ST, LLC (U.S.), and Union Biometrica, Inc. (U.S.).
Download Free Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=62606262
The key players in this market are focusing to strengthen their position in emerging markets by adopting both organic and inorganic growth strategies. For instance, in September 2016, Miltenyi Biotec GmbH (Germany) launched the Miltenyi Biotec Cell Therapy Centre of Excellence at the Monash Health Translation Precinct (MHTP), Australia. The new facility hosts a number of cell therapy products, including the company’s MACSQuant Tyto GMP Cell Sorter used for the development of treatment options for various diseases. Likewise, in August 2013, Sony Biotechnology, Inc. (U.S.) announced its operational expansion in the European region and showcased its SH800 Cell Sorter at the International Congress of Immunology (ICI) held in Milan, Italy. The company’s European head office is now located in the U.K. and support its England and France sales offices.
In addition, emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for market players owing to the growing incidence and prevalence of diseases such as cancer and HIV/AIDS, increasing research initiatives, and rising focus of market leaders in these countries. In India, the number of people diagnosed with cancer in 2012 increased to 14.1 million from an estimated 12.7 million in 2008 (Source: GLOBOCAN 2012). GLOBOCAN 2012 further estimates that the incidence of cancer will increase to ~19.3 million cases by 2025. Additionally, China’s health officials stated that in 2014, there were 104,000 new HIV/AIDS infections in China, a 14.8% increase from 2013 (Source: Dow Jones & Company, Inc.).
0 Comments